PHASE-I TRIAL OF INTRAVENOUS CONTINUOUS INFUSION OF TUMOR NECROSIS FACTOR IN ADVANCED METASTATIC CARCINOMAS

被引：57
|
作者：
WIEDENMANN, B
REICHARDT, P
RATH, U
THEILMANN, L
SCHULE, B
HO, AD
SCHLICK, E
KEMPENI, J
HUNSTEIN, W
KOMMERELL, B
机构：
[1] UNIV HEIDELBERG,MED POLIKLIN,D-6900 HEIDELBERG,FED REP GER
[2] KNOLL AG,D-6700 LUDWIGSHAFEN,FED REP GER
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1989年 / 115卷 / 02期
关键词：
D O I：
10.1007/BF00397922
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：189 / 192
页数：4
相关论文
共 50 条
  • [1] PHASE-I STUDY OF TUMOR-NECROSIS-FACTOR (TNF) ADMINISTERED BY CONTINUOUS INTRAVENOUS-INFUSION TO CANCER-PATIENTS
    HERSH, EM
    SCHWARTZ, J
    SCUDERI, P
    [J]. IMMUNOBIOLOGY, 1987, 175 (1-2) : 94 - 95
  • [2] PHASE-I STUDY OF 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR
    STEINMETZ, T
    SCHAADT, M
    GAHL, R
    SCHENK, V
    DIEHL, V
    PFREUNDSCHUH, M
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1988, 7 (05): : 417 - 423
  • [3] PHASE-I TRIAL OF INTRAMUSCULARLY ADMINISTERED TUMOR NECROSIS FACTOR IN PATIENTS WITH ADVANCED CANCER
    JAKUBOWSKI, AA
    CASPER, ES
    GABRILOVE, JL
    TEMPLETON, MA
    SHERWIN, SA
    OETTGEN, HF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 298 - 303
  • [4] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. BLUT, 1986, 53 (03): : 231 - 232
  • [5] INTRAVENOUS VINCRISTINE INFUSION - PHASE-I TRIAL
    JACKSON, DV
    SETHI, VS
    SPURR, CL
    WILLARD, V
    WHITE, DR
    RICHARDS, F
    STUART, JJ
    MUSS, HB
    COOPER, MR
    HOMESLEY, HD
    JOBSON, VW
    CASTLE, MC
    [J]. CANCER, 1981, 48 (12) : 2559 - 2564
  • [6] PHASE-I TRIAL OF DOXIFLURIDINE (5'DFUR) CONTINUOUS INTRAVENOUS-INFUSION IN ADVANCED SOLID TUMORS
    HEIM, ME
    GRAUF, U
    SCHUSTER, D
    CALCANIS, A
    DRINGS, P
    QUEISSER, W
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 187 - 187
  • [7] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (TNF) IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 99 - 99
  • [8] A PHASE-I TRIAL OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR TO PATIENTS WITH ADVANCED MALIGNANCY
    ZAMKOFF, KW
    NEWMAN, NB
    RUDOLPH, AR
    YOUNG, J
    POIESZ, BJ
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (05): : 539 - 552
  • [9] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR (RTNF) IN PATIENTS WITH ADVANCED MALIGNANCY
    KRIGEL, R
    COMIS, R
    PADAVIC, K
    RUDOLPH, A
    [J]. CLINICAL RESEARCH, 1987, 35 (05): : A806 - A806
  • [10] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (TNF) IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. IMMUNOBIOLOGY, 1987, 175 (1-2) : 22 - 22
12345